patents

Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Fierce Pharma
Pfizer
patents
UK
Lyrica
Flag link:
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit
RAPS.org
Boehringer Ingelheim
AbbVie
Humira
patents
biosimilars
Flag link:
UC Regents issued 2nd CRISPR patent in U.S.
UC Regents issued 2nd CRISPR patent in U.S.
BioCentury
University of California
CRISPR
patents
Flag link:
Mylan's generic Copaxone wins in court, but market barriers remain
Mylan's generic Copaxone wins in court, but market barriers remain
Biopharma Dive
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
Flag link:
In The Battle To Control Drug Costs, Old Patent Laws Get New Life
In The Battle To Control Drug Costs, Old Patent Laws Get New Life
Kaiser Health News
patents
drug pricing
Flag link:
Appeals court overturns patent board in Bard spat with AngioDynamics
Appeals court overturns patent board in Bard spat with AngioDynamics
Mass Device
devices
CR Bard
Becton Dickinson
AngioDynamics
patents
Flag link:
Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
NPR
patents
Purdue Pharma
competition
opioids
Flag link:
New Patent Database to Help Governments Procure Medicines
New Patent Database to Help Governments Procure Medicines
RAPS.org
patents
Flag link:
Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Biopharma Dive
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
patents
Flag link:
Appeals court upholds CRISPR patents awarded to the Broad Institute
Appeals court upholds CRISPR patents awarded to the Broad Institute
Stat
CRISPR
patents
Broad Institute
University of California
Flag link:
[sponsored] Orange Book Companion® Adds New Features and Capabilities
[sponsored] Orange Book Companion® Adds New Features and Capabilities
CP Wire
patents
Hatch Waxman Act
FDA
exclusivity
Flag link:
[sponsored] Orange Book Companion® Adds New Features and Capabilities
patents
Hatch Waxman Act
FDA
exclusivity
Flag link:
Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals
Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals
Fierce Pharma
Novartis
Gleevec
patents
Flag link:
In Pharma Patent Disputes, Data Rules Over Intuition And (Gasp!) Legal Judgment
In Pharma Patent Disputes, Data Rules Over Intuition And (Gasp!) Legal Judgment
Forbes
patents
patent lawsuits
Flag link:
How Companies Protect Intellectual Property Involving Live Microbes - Interview With a Patent Attorney
How Companies Protect Intellectual Property Involving Live Microbes - Interview With a Patent Attorney
CP Wire
patents
microbiome
microbe
intellectual property
Flag link:
Microbiome Report for the week ending 7-29-18
Microbiome Report for the week ending 7-29-18
CP Wire
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Flag link:
Microbiome Report for the week ending 7-29-18
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Flag link:
Pfizer Wins Remicade Patent Case Over J&J
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Pfizer
Celltrion
JNJ
Janssen
patents
Remicade
Flag link:
Omeros Prevails in Patent Dispute With Sandoz
Omeros Prevails in Patent Dispute With Sandoz
CP Wire
Omeros
Sandoz
Novartis
patents
Omidria
Flag link:
On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019
On top of expiring Herceptin patents, Roche faces huge royalty losses in 2019
Endpoints
Roche
patents
Herceptin
Cabilly patents
Flag link:

Pages